Open Actively Recruiting

NOLA (NeuWave Observational Liver Ablation) Registry

About

Brief Summary

This is a multicenter, observational registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the NEUWAVE Microwave Ablation System.

Study Type
Observational
Phase
N/A

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
22 Years
Maximum Age
N/A

Inclusion Criteria:

  • Patients who underwent or are scheduled to undergo a microwave ablation of one or more liver lesions with the NEUWAVE Microwave Ablation System per the device's Instructions for Use (IFU).
  • Patients with signed informed consent (or waiver approved by IRB/EC) who are willing to comply with the assessment schedule, and willing to have data included in the database.
  • Patients greater than or equal to 22 years old at the time of informed consent (or waiver approved by IRB/EC).

Exclusion Criteria:

  • Patients with a life expectancy of less than 1 year, in the opinion of the treating physician.
  • Use of microwave ablation purely as a transection tool, rather than focused liver lesion ablation.
  • Patient is currently participating, or planning to participate, in another NeuWave/Ethicon-funded clinical trial or registry studying microwave ablation in the liver. Note: roll-over patients from previous NeuWave trials are permitted.

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
19-001698
Category
Oncology
Radiological Sciences
Contact
Arineh Aghakhani
Location
  • UCLA Westwood
For Providers
NCT No.
NCT04107766
For detailed technical eligibility, visit ClinicalTrials.gov.